Discover Products, Get Discovered.
Individuals find the right products. Businesses reach the right audience. One platform, free for both.
Individuals find the right products. Businesses reach the right audience. One platform, free for both.
Since 2021, Lireas has backed 2 African startups across 3 disclosed funding rounds totaling $71.8M, most heavily in South Africa and Fintech.
Lireas is the strategic investment arm of Hannover Reinsurance Group Africa, operating as a corporate venture capital investor. Official materials describe it as a CVC model focused on strategic investment activity. In Africa, Lireas has backed companies in South Africa across fintech and health tech. Based on the provided investment records, its activity spans Seed, Series A, and Series B rounds, with confirmed investments in Pineapple and LifeQ. Its disclosed Africa portfolio shows a clear preference for South African startups, with all recorded activity in that market.
Data updated · Jul 29, 2026
Lireas has backed 2 African startups across 3 disclosed funding rounds tracked on Liners, totaling $71.8M since 2021.
Mostly Series A: 2 of its 3 tracked rounds are at that stage, followed by Series B (1).
Lireas's tracked rounds are concentrated in South Africa (3).
Its tracked rounds lean toward Fintech (2), Health Tech (1).
Lireas most often shares rounds with ASISA Enterprise and Supplier Development Fund (2 shared deals), E4E Africa (2 shared deals), Old Mutual Investment Group (2 shared deals).
Lireas is the strategic investment arm of Hannover Reinsurance Group Africa and operates on a corporate venture capital model. Its official materials describe it as a CVC-focused investor.
The confirmed Africa portfolio in the provided records includes Pineapple and LifeQ. Pineapple received backing in Series A and Series B rounds, while LifeQ received Series A funding.
